These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33320406)

  • 1. A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study.
    Abdel-Raouf H; Aly UF; Medhat W; Ahmed SS; Abdel-Aziz RTA
    Dermatol Ther; 2021 Jan; 34(1):e14678. PubMed ID: 33320406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the efficacy and quality of Life improvements of botulinum toxin type a with topical minoxidil versus topical minoxidil in male androgenetic alopecia: a randomized controlled trial.
    Yu L; Moorthy S; Li X; Peng L; Zhang Z; Shen L; Han Y; Huang X
    Arch Dermatol Res; 2024 Aug; 316(8):532. PubMed ID: 39154106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.
    Penha MA; Miot HA; Kasprzak M; Müller Ramos P
    JAMA Dermatol; 2024 Jun; 160(6):600-605. PubMed ID: 38598226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical cetirizine for treating androgenetic alopecia: A systematic review.
    Chen X; Xiang H; Yang M
    J Cosmet Dermatol; 2022 Nov; 21(11):5519-5526. PubMed ID: 35976065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigator-blinded, controlled, and randomized comparative study on 1565 nm non-ablative fractional laser versus 5% minoxidil for treatment of androgenetic alopecia.
    Qu H; Zhang R; Xin W; Jing H; Wang G; Gao L
    J Cosmet Dermatol; 2024 May; 23(5):1638-1644. PubMed ID: 38247260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing low-dose oral minoxidil efficacy in androgenetic alopecia: a comparative study of AGA and AGA unmasked by telogen effluvium.
    Desai DD; Nohria A; Sikora M; Anyanwu N; Shapiro J; Lo Sicco KI
    Arch Dermatol Res; 2024 Aug; 316(8):514. PubMed ID: 39133308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Split-scalp pilot study to evaluate effectiveness of Minoxidil 0,5% MMP® versus Topical Minoxidil 5% in the treatment of Female Pattern Hair Loss.
    Corrêa AC; Machado CJ; Carneiro SCS
    Arch Dermatol Res; 2024 Jun; 316(6):313. PubMed ID: 38822940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To evaluate hypertrichosis with low dose oral minoxidil and spironolactone combination therapy for alopecia.
    Nohria A; Desai D; Sikora M; Mandal S; Caplan A; Shapiro J; Sicco KIL
    Arch Dermatol Res; 2024 Aug; 316(8):510. PubMed ID: 39133327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hair follicle sulfotransferase activity and effectiveness of oral minoxidil in androgenetic alopecia.
    Jimenez-Cauhe J; Vaño-Galvan S; Mehta N; Hermosa-Gelbard A; Ortega-Quijano D; Buendia-Castaño D; Fernández-Nieto D; Porriño-Bustamante M; Saceda-Corralo D; Pindado-Ortega C; Moreno-Arrones OM; Wambier C; Dhura R; Lotti T; Goren A
    J Cosmet Dermatol; 2024 Jul; ():. PubMed ID: 39034734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microneedle Delivery Platform Integrated with Codelivery Nanoliposomes for Effective and Safe Androgenetic Alopecia Treatment.
    Zhang S; Zhou H; Chen X; Zhu S; Chen D; Luo D; Chen S; Liu W
    ACS Appl Mater Interfaces; 2024 Apr; 16(13):15701-15717. PubMed ID: 38507687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of spironolactone versus bicalutamide in female pattern hair loss: A retrospective comparative study.
    Jha AK; Zeeshan MD; Singh A; Singh AK
    Australas J Dermatol; 2024 Aug; 65(5):437-443. PubMed ID: 38762801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful topical minoxidil treatment for hair density and length in trichorhinophalangeal syndrome type 1.
    Choi M; Han A; Eichenfield LF
    Pediatr Dermatol; 2024; 41(2):366-368. PubMed ID: 38193387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Study to Evaluate Tolerability of Topical 5% Minoxidil Novel Formulation and Alcohol-Based Conventional Solutions in Treatment of Androgenetic Alopecia in Indian Men: Randomized Double-Blind Study.
    Sarkar R; Vartak S; Acharya S; Kursam NK; Mane A; Mehta S; Charugulla SN
    Dermatol Ther (Heidelb); 2020 Jun; 10(3):469-479. PubMed ID: 32277388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic treatment of androgenetic alopecia with follicular co-delivery of minoxidil and cedrol in metal-organic frameworks stabilized by covalently cross-linked cyclodextrins.
    He Z; Zhang Y; Liu Z; Guo T; Ai X; He Y; Hou X; Feng N
    Int J Pharm; 2024 Apr; 654():123948. PubMed ID: 38417724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic therapeutic effect of ginsenoside Rg3 modified minoxidil transfersomes (MXD-Rg3@TFs) on androgenic alopecia in C57BL/6 mice.
    Liu X; Kong X; Xu L; Su Y; Xu S; Pang X; Wang R; Ma Y; Tian Q; Han L
    Int J Pharm; 2024 Apr; 654():123963. PubMed ID: 38430952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of hair regrowth in an animal model of androgenic alopecia using 2-deoxy-D-ribose.
    Anjum MA; Zulfiqar S; Chaudhary AA; Rehman IU; Bullock AJ; Yar M; MacNeil S
    Front Pharmacol; 2024; 15():1370833. PubMed ID: 38887556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Minoxidil Treatment in Scarring Alopecia: A Scoping Review.
    Ly N; McClure EM; Hordinsky MK; Farah RS; Park SY
    J Drugs Dermatol; 2024 Mar; 23(3):146-151. PubMed ID: 38443124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgenetic Alopecia in Men: An Update On Genetics.
    Sadasivam IP; Sambandam R; Kaliyaperumal D; Dileep JE
    Indian J Dermatol; 2024; 69(3):282. PubMed ID: 39119311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Minoxidil Overdose in a Young Man With Androgenetic Alopecia: A Case Report.
    Ponomareva MA; Romanova MA; Shaposhnikova AA; Piavchenko GA
    Cureus; 2024 Jun; 16(6):e62382. PubMed ID: 39006707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hydroxypropyl-β-cyclodextrin-minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia.
    Maqoud F; Zizzo N; Mele A; Denora N; Passantino G; Scala R; Cutrignelli A; Tinelli A; Laquintana V; la Forgia F; Fontana S; Franco M; Lopedota AA; Tricarico D
    Pharmacol Res Perspect; 2020 Jun; 8(3):e00585. PubMed ID: 32378360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.